Grant Opportunities in Life Science
Bridging Research and Resources for Tomorrow's Discoveries
Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
Pfizer Inc. invites proposals for educational programs on the mechanism of action of JAK3 and TEC family kinases in alopecia areata for dermatologists and healthcare professionals.
Published At
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
The National Cancer Institute (NCI) solicits applications from academic organizations to establish Lead Academic Organizations within the ETCTN clinical trials network.
Published At
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)
The National Cancer Institute (NCI) seeks applications from institutions to establish a Pharmacokinetic Resource Laboratory to support the ETCTN clinical trials network.
Published At
Developing Educational Initiatives for Implementation and Therapy Management of B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
Pfizer offers grants up to $125,000 to US healthcare organizations to improve professional competency in managing BCMA BsAbs for Relapsed/Refractory Multiple Myeloma.
Published At
Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
Pfizer Inc. offers a research grant for medical societies and professional organizations to develop a shared decision-making tool for patients with ATTR-CM.
Published At
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
The National Institutes of Health (NIH) provides grants for Animal and Biological Material Resource Centers to support laboratory animal colonies and biomedical research resources.
Published At
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
NIAID offers R24 grants for investigator-initiated resource-related research projects to support the development of new resources for the scientific community.
Published At
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies (R01 - Clinical Trial Optional)
The National Institutes of Health supports research into AI/ML-driven tools and glucose control technologies to improve glycemic control and quality of life for people with T1D.
Published At
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
NIAID invites P01 applications for research on infectious microbes, HIV, and immune dysfunction. Supports synergistic research projects and administrative cores.
Published At
Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC)
NIH is issuing a single source cooperative agreement to Brigham and Women's Hospital to support the AMP® SCZ Data Processing, Analysis, and Coordination Center (DPACC).
Published At